7776 logo

CellSeed Inc. Stock Price

TSE:7776 Community·JP¥11.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

7776 Share Price Performance

JP¥0
-605.00 (-100.00%)
JP¥0
-605.00 (-100.00%)
Price JP¥0

7776 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

CellSeed Inc. Key Details

JP¥161.0m

Revenue

JP¥98.0m

Cost of Revenue

JP¥63.0m

Gross Profit

JP¥977.0m

Other Expenses

-JP¥914.0m

Earnings

Last Reported Earnings
Dec 31, 2021
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About 7776

Founded
2001
Employees
n/a
CEO
Setsuko Hashimoto
WebsiteView website
www.cellseed.com

CellSeed Inc. engages in the cell sheet regenerative medicine business in Japan, the rest of Asia, and Europe. It operates through Regenerative Medicine Support Business and Cell Sheet Regenerative Medicine Business segments. The company is involved in commercializing regenerative medicine using cell sheets, which include autologous and allogeneic chondrocyte sheets. It also offers regenerative medicine contract services comprising contract development and manufacturing; contract manufacturing and consulting for specified cell-based products; and training and education in cell culturing technology services. In addition, the company provides UpCell, a temperature-responsive cell cultureware for cell sheet engineering; RepCell, a temperature-responsive cell cultureware for cell collection; HydroCell, a low cell binding cultureware; ThermoPlate III, a heating element made of a transparent glass plate; cellZscope, an automated cell monitoring system; and cell sheet support products. CellSeed Inc. was incorporated in 2001 and is headquartered in Koto, Japan.

Recent 7776 News & Updates

Recent updates

No updates